CFO
RTO icon

Callan Family Office’s Rentokil RTO Stock Holding History

Callan Family Office’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$451K Sell
14,315
-568
-4% -$17.9K 0.01% 803
2025
Q4 		$438K Buy
+14,883
New +$413K 0.01% 816
2025
Q3 		– Sell
-8,921
Closed -$214K – 932
2025
Q2 		$214K Buy
+8,921
New +$207K 0.01% 878

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return

Callan Family Office's RTO Position: Q1 2026 in Review

Callan Family Office reduced its Rentokil (RTO) stake by 3.8% in Q1 2026, selling an estimated $17.9K and leaving 14,315 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #803.

Callan Family Office first reported a position in RTO in Q2 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Callan Family Office held 14,315 shares of Rentokil worth $451K as of Q1 2026.
  • Callan Family Office sold 568 Rentokil shares in Q1 2026, an estimated $17.9K.
  • Rentokil made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #803 holding.
  • Callan Family Office first reported a position in Rentokil in Q2 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.